Expertise
Our successful track record in pharmaceutical R&D includes supporting over 20 candidates into clinical development.
Experimental
Diabetes
We offer a range of in vitro and in vivo assays for evaluating compounds with antidiabetic activity.
Obesity
Our animal models of obesity can be used to predict the effects of drugs on body weight and metabolic risk factors in man.
CNS Disorders
We employ innovative techniques to evaluate drugs to treat psychiatric and neurological conditions.
Drug Abuse Liability
RenaSci is part of ALTeC - a collaboration for assessing drug abuse liability in animals and man.
